Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Xtant Medical Holdings (XTNT) over the last 10 years, with Q3 2025 value amounting to $828000.0.

  • Xtant Medical Holdings' Asset Writedowns and Impairment rose 16970.68% to $828000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 6941.9%. This contributed to the annual value of $485000.0 for FY2024, which is 3585.43% up from last year.
  • According to the latest figures from Q3 2025, Xtant Medical Holdings' Asset Writedowns and Impairment is $828000.0, which was up 16970.68% from -$51000.0 recorded in Q2 2025.
  • Xtant Medical Holdings' 5-year Asset Writedowns and Impairment high stood at $828000.0 for Q3 2025, and its period low was -$210000.0 during Q4 2024.
  • Moreover, its 5-year median value for Asset Writedowns and Impairment was $153000.0 (2023), whereas its average is $206157.9.
  • Per our database at Business Quant, Xtant Medical Holdings' Asset Writedowns and Impairment skyrocketed by 232727.27% in 2021 and then plummeted by 41219.51% in 2024.
  • Quarter analysis of 5 years shows Xtant Medical Holdings' Asset Writedowns and Impairment stood at $267000.0 in 2021, then decreased by 8.61% to $244000.0 in 2022, then plummeted by 116.8% to -$41000.0 in 2023, then tumbled by 412.2% to -$210000.0 in 2024, then surged by 494.29% to $828000.0 in 2025.
  • Its Asset Writedowns and Impairment was $828000.0 in Q3 2025, compared to -$51000.0 in Q2 2025 and $541000.0 in Q1 2025.